DRD2, dopamine receptor D2, 1813

N. diseases: 437; N. variants: 42
Disease: Extrapyramidal Disorders ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0015371
Disease: Extrapyramidal Disorders
Extrapyramidal Disorders 		0.310 Biomarker group CTD_human A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. 19506579 2009
CUI: C0015371
Disease: Extrapyramidal Disorders
Extrapyramidal Disorders 		0.310 Biomarker group CTD_human Sensitivity of older patients to antipsychotic motor side effects: a PET study examining potential mechanisms. 19225277 2009
CUI: C0015371
Disease: Extrapyramidal Disorders
Extrapyramidal Disorders 		0.310 Biomarker group CTD_human Aripiprazole-induced parkinsonism and its association with dopamine and serotonin receptor polymorphisms. 18480698 2008
CUI: C0015371
Disease: Extrapyramidal Disorders
Extrapyramidal Disorders 		0.310 GeneticVariation group BEFREE Association of DRD2 polymorphisms and chlorpromazine-induced extrapyramidal syndrome in Chinese schizophrenic patients. 16867246 2006
CUI: C0015371
Disease: Extrapyramidal Disorders
Extrapyramidal Disorders 		0.310 Biomarker group CTD_human Prediction and assessment of extrapyramidal side effects induced by risperidone based on dopamine D(2) receptor occupancy. 12211096 2002
CUI: C0015371
Disease: Extrapyramidal Disorders
Extrapyramidal Disorders 		0.310 Biomarker group CTD_human D2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study. 11198054 2000